These exorbitant costs have made it extremely challenging to be able to continue to provide drug coverage to everyone who wants these drugs but does not have an FDA-approved medical or indication for these drugs, the company stated
Combining meaningful weight loss with proven cardiovascular benefits in an oral formulation could be a game changer for both patients and healthcare providers
GLP-1 plays a role in insulin release and blood sugar regulation and also interacts with areas of the brain involved in appetite signaling
SUBJECT MATTER EXPERTS, CASE STUDY INTERVIEWEES, AND STATE OFFICIALS Subject Matter Experts Catherine Anderson, Vice President of State Programs, UnitedHealthcare Community & State Rich Bringewatt Co-Founder and Chair, SNP Alliance and Pam Parker, Medicare-Medicaid Integration Consultant, SNP Alliance Rhys Jones, Vice President Medicaid Advocacy
Available from: A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)